These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 15981158

  • 1. [Change of interleukin-4 and interleukin-12 levels after therapy of multiple sclerosis relapse with methylprednisolone].
    Bartosik-Psujek H, Magryś A, Montewka-Kozioł M, Stelmasiak Z.
    Neurol Neurochir Pol; 2005; 39(3):207-12. PubMed ID: 15981158
    [Abstract] [Full Text] [Related]

  • 2. Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
    Rentzos M, Nikolaou C, Rombos A, Evangelopoulos ME, Kararizou E, Koutsis G, Zoga M, Dimitrakopoulos A, Tsoutsou A, Sfangos C.
    Clin Neurol Neurosurg; 2008 Dec; 110(10):992-6. PubMed ID: 18657352
    [Abstract] [Full Text] [Related]

  • 3. CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone.
    Szczuciński A, Kalinowska A, Losy J.
    Eur Neurol; 2007 Dec; 58(4):228-32. PubMed ID: 17827967
    [Abstract] [Full Text] [Related]

  • 4. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
    Ravnborg M, Sørensen PS, Andersson M, Celius EG, Jongen PJ, Elovaara I, Bartholomé E, Constantinescu CS, Beer K, Garde E, Sperling B.
    Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
    [Abstract] [Full Text] [Related]

  • 5. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Sorensen PS, Mellgren SI, Svenningsson A, Elovaara I, Frederiksen JL, Beiske AG, Myhr KM, Søgaard LV, Olsen IC, Sandberg-Wollheim M.
    Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
    [Abstract] [Full Text] [Related]

  • 6. Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients.
    Tawfik TZ, Gad AH, Mehaney DA, El Nahrery E, Shehata HS, Hashem H, Ghaffar NFA, Shalaby N.
    J Neurol Sci; 2016 Oct 15; 369():36-38. PubMed ID: 27653861
    [Abstract] [Full Text] [Related]

  • 7. Atorvastatin calcium in combination with methylprednisolone for the treatment of multiple sclerosis relapse.
    Li XL, Zhang ZC, Zhang B, Jiang H, Yu CM, Zhang WJ, Yan X, Wang MX.
    Int Immunopharmacol; 2014 Dec 15; 23(2):546-9. PubMed ID: 25448497
    [Abstract] [Full Text] [Related]

  • 8. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.
    Trenova AG, Manova MG, Kostadinova II, Murdjeva MA, Hristova DR, Vasileva TV, Zahariev ZI.
    Folia Med (Plovdiv); 2011 Dec 15; 53(2):29-35. PubMed ID: 21797104
    [Abstract] [Full Text] [Related]

  • 9. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA, Tilbery CP, Monteiro LP, Teixeira MM, Teixeira AL.
    Acta Neurol Scand; 2006 Aug 15; 114(2):109-13. PubMed ID: 16867033
    [Abstract] [Full Text] [Related]

  • 10. Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse.
    Rentzos M, Nikolaou C, Rombos A, Evangelopoulos ME, Dimitrakopoulos A, Kararizou E, Koutsis G, Zoga M, Tsoutsou A, Sfangos K.
    Neurol Res; 2010 Sep 15; 32(7):684-9. PubMed ID: 19703339
    [Abstract] [Full Text] [Related]

  • 11. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
    Lindquist S, Hassinger S, Lindquist JA, Sailer M.
    Mult Scler; 2011 Jul 15; 17(7):851-66. PubMed ID: 21561957
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale.
    Pascual AM, Boscá I, Coret F, Escutia M, Bernat A, Casanova B.
    Eur J Neurol; 2008 Mar 15; 15(3):284-8. PubMed ID: 18290849
    [Abstract] [Full Text] [Related]

  • 13. Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.
    Bartosik-Psujek H, Stelmasiak Z.
    Eur Neurol; 2004 Mar 15; 52(4):237-41. PubMed ID: 15550762
    [Abstract] [Full Text] [Related]

  • 14. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 15. Long-term effect of high doses glucocorticosteroids on mRNA expression for IL-6 and IL-8 in relapsed multiple sclerosis patients.
    Mirowska-Guzel D, Gromadzka G, Kurowska K, Czlonkowski A, Czlonkowska A.
    Immunopharmacol Immunotoxicol; 2010 Sep 15; 32(3):416-21. PubMed ID: 20095806
    [Abstract] [Full Text] [Related]

  • 16. The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
    Babaloo Z, Aliparasti MR, Babaiea F, Almasi S, Baradaran B, Farhoudi M.
    Immunol Lett; 2015 Apr 15; 164(2):76-80. PubMed ID: 25625963
    [Abstract] [Full Text] [Related]

  • 17. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr 15; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
    Lacka K, Manuszewska E, Korczowska I, Lacki JK.
    Curr Eye Res; 2007 Mar 15; 32(3):291-7. PubMed ID: 17453949
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.